Drug Profile
Research programme: alpha-galactosidase - Large Scale Biology Corporation
Alternative Names: ENZAGAL; human alpha-galactosidase ALatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Large Scale Biology Corporation (CEASED)
- Class Enzymes; Proteins
- Mechanism of Action Enzyme replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Fabry's disease
Most Recent Events
- 23 Dec 2005 Large Scale Biology Corporation ceased operations
- 23 Sep 2005 Large Scale Biology Corporation and Icon Genetics announced the initiation of the commercial phase of their collaborative agreement for an undisclosed product for enzyme replacement therapy
- 22 Jan 2004 Large Scale Biology Corporation has announced positive preclinical data for alpha-galactosidase A for Fabry's disease